Generate Biomedicines pushes machine learning to create new protein drugs
Generate Biomedicines is using machine learning in the U.S. to design new protein drugs. Its pipeline includes candidates for severe asthma and CAR-T cell therapy.
Protein Engineering 1 article
Protein Engineering changes amino acid sequence or molecular architecture to alter protein function. Directed evolution, rational design, enzyme engineering, antibody engineering and optimization of stability, affinity or specificity belong when sequence-structure-function relationships guide the work. The section is not about cell-state engineering or tissue regeneration: its unit of design is the protein itself, whether the application is therapeutic, diagnostic, industrial or experimental.